Dopamine D2-agonist Rotigotine effects on cortical excitability and central cholinergic transmission in Alzheimer's disease patients

Neuropharmacology

Volumn 64, Issue , 2013, Pages 108-113

  Martorana, Alessandro ^a,b   Di Lorenzo, Francesco ^b   Esposito, Zaira ^a   Lo Giudice, Temistocle ^a   Bernardi, Giorgio ^b   Caltagirone, Carlo ^b   Koch, Giacomo ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Alzheimer's disease; D2 agonists; Dopamine; SICI; SLAI; TMS

Indexed keywords

DOPAMINE 2 RECEPTOR; ROTIGOTINE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN FUNCTION; CHOLINERGIC TRANSMISSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL EXCITABILITY; DOSE RESPONSE; DRUG ACTIVITY; HUMAN; INTRACORTICAL FACILITATION; NERVOUS SYSTEM ELECTROPHYSIOLOGY; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; SHORT INTRACORTICAL INHIBITION; SHORT LATENCY AFFERENT INHIBITION;

AGED; ALZHEIMER DISEASE; CEREBRAL CORTEX; CHOLINERGIC NEURONS; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GABAERGIC NEURONS; HUMANS; MIDDLE AGED; NEURAL INHIBITION; NEURONAL PLASTICITY; NOOTROPIC AGENTS; RECEPTORS, DOPAMINE D2; SINGLE-BLIND METHOD; SYNAPTIC TRANSMISSION; TETRAHYDRONAPHTHALENES; THIOPHENES; TRANSCRANIAL MAGNETIC STIMULATION; TRANSDERMAL PATCH;

EID: 84866386460     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.07.015     Document Type: Article

References (69)

1. A. Alberici, C. Bonato, M. Calabria, C. Agosti, O. Zanetti, C. Miniussi, A. Padovani, P.M. Rossini, and B. Borroni The contribution of TMS to frontotemporal dementia variants Acta Neurol. Scand. 118 4 2008 Oct 275 280
2. H. Alle, T. Heidegger, L. Kriváneková, and U. Ziemann Interactions between short-interval intracortical inhibition and short-latency afferent inhibition in human motor cortex J. Physiol. 587 Pt 21 2009 Nov 1 5163 5176
3. 5 receptor localization on cholinergic neurons of the rat forebrain and diencephalon: a potential neuroanatomical substrate involved in mediating dopaminergic influences on acetylcholine release J. Comp. Neurol. 492 1 2005 Nov 7 34 49
4. M.J. Brilliant, R.J. Elble, M. Ghobrial, and R.G. Struble The distribution of amyloid beta protein deposition in the corpus striatum of patients with Alzheimer's disease Neuropathol. Appl. Neurobiol. 23 4 1997 Aug 322 325
5. 2-like receptors in nucleus accumbens negatively modulate acetylcholine release in prefrontal cortex Neuropharmacology 53 2007 455 463
6. G.A. Carlesimo, C. Caltagirone, and G. Gainotti The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery Eur. Neurol. 36 1996 378 384
7. L.W. de Jong, L. Ferrarini, J. van der Grond, J.R. Milles, J.H. Reiber, R.G. Westendorp, E.L. Bollen, H.A. Middelkoop, and M.A. van Buchem Shape abnormalities of the striatum in Alzheimer's disease J. Alzheimers Dis. 23 1 2011 49 59
8. L.W. de Jong, Y. Wang, L.R. White, B. Yu, M.A. van Buchem, and L.J. Launer Ventral striatal volume is associated with cognitive decline in older people: a population based MR-study Neurobiol. Aging 33 2 2012 Feb 424.e1 424.e10
9. 2 receptors in the prefrontal cortex reduces PCP-induced hyperactivity, acetylcholine release and dopamine metabolism in the nucleus accumbens J. Neural Transm. 114 2007 185 193
10. V. Di Lazzaro, A. Oliviero, and P.A. Tonali Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation Neurology 13 2002 392 397
11. V. Di Lazzaro, A. Oliviero, F. Pilato, E. Saturno, M. Dileone, C. Marra, A. Daniele, S. Ghirlanda, G. Gainotti, and P.A. Tonali Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease J. Neurol. Neurosurg. Psychiatry 75 4 2004 Apr 555 559
12. V. Di Lazzaro, A. Oliviero, F. Pilato, E. Saturno, M. Dileone, C. Marra, S. Ghirlanda, F. Ranieri, G. Gainotti, and P. Tonali Neurophysiological predictors of long term response to AChE inhibitors in AD patients J. Neurol. Neurosurg. Psychiatry 76 8 2005 Aug 1064 1069
13. V. Di Lazzaro, F. Pilato, M. Dileone, E. Saturno, P. Profice, C. Marra, A. Daniele, F. Ranieri, D. Quaranta, G. Gainotti, and P.A. Tonali Functional evaluation of cerebral cortex in dementia with Lewy bodies Neuroimage 37 2 2007 Aug 15 422 429
14. V. Di Lazzaro, F. Pilato, M. Dileone, P. Profice, C. Marra, F. Ranieri, D. Quaranta, G. Gainotti, and P.A. Tonali In vivo functional evaluation of central cholinergic circuits in vascular dementia Clin. Neurophysiol. 119 11 2008 Nov 2494 2500
15. P.T. Francis The interplay of neurotransmitters in Alzheimer's disease CNS Spectr. 10 11 Suppl. 18 2005 Nov 6 9
16. C. Freitas, H. Mondragón-Llorca, and A. Pascual-Leone Noninvasive brain stimulation in Alzheimer's disease: systematic review and perspectives for the future Exp. Gerontol. 46 8 2011 Aug 611 627
17. P.S. Goldman-Rakic, C. Bergson, L.S. Krimer, M.S. Lidow, S.M. William, and G.V. Williams The primate mesocortical dopamine system F.E. Bloom, A. Bjorklund, T. Hokfelt, Handbook of Chemical Neuroanatomy: the Primate Nervous System, Pt III 1999 Elsevier Amsterdam 403 428
18. P.S. Goldman-Rakic, E.C. Muly 3rd, and G.V. Williams D(1) receptors in prefrontal cells and circuits Brain Res. Brain Res. Rev. 31 2-3 2000 295 301
19. A.T. Gulledge, and D.B. Jaffe Dopamine decreases the excitability of layer V pyramidal cells in the rat prefrontal cortex J. Neurosci. 18 21 1998 Nov 1 9139 9151
20. E. Himeno, Y. Ohyagi, L. Ma, N. Nakamura, K. Miyoshi, N. Sakae, K. Motomura, N. Soejima, R. Yamasaki, T. Hashimoto, T. Tabira, F.M. LaFerla, and J. Kira Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation Ann. Neurol. 69 2011 248 256
21. J.A. Hosp, K. Molina-Luna, B. Hertler, C.O. Atiemo, and A.R. Luft Dopaminergic modulation of motor maps in rat motor cortex: an in vivo study Neuroscience 159 2 2009 Mar 17 692 700
22. J.A. Hosp, A. Pekanovic, M.S. Rioult-Pedotti, and A.R. Luft Dopaminergic projections from midbrain to primary motor cortex mediate motor skill learning J. Neurosci. 31 7 2011 Feb 16 2481 2487
23. 2-like receptors in human striatum Synapse 63 4 2009 Apr 282 290
24. A. Itoh, A. Nitta, M. Nadai, K. Nishimura, M. Hirose, T. Hasegawa, and T. Nabeshima Dysfunction of cholinergic and dopaminergic neuronal systems in beta-amyloid protein-infused rats J. Neurochem. 66 3 1996 Mar 1113 1117
25. 2 receptor bands in normal human temporal cortex are absent in Alzheimer's disease Brain Res. 784 1-2 1998 Feb 16 7 17
26. 5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomers J. Biol. Chem. 286 5 2011 Feb 4 3270 3276
27. A. Kastner, E.C. Hirsch, M.T. Herrero, F. Javoy-Agid, and Y. Agid Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease J.Neurochem 61 3 1993 Sep 1024 1034
28. 2 receptors correlate with memory functions in Alzheimer's disease Eur. J. Neurosci. 18 2003 149 154
29. S. Kröner, L.S. Krimer, D.A. Lewis, and G. Barrionuevo Dopamine increases inhibition in the monkey dorsolateral prefrontal cortex through cell type-specific modulation of interneurons Cereb. Cortex 17 5 2007 May 1020 1032
30. T. Kujirai, M.D. Caramia, J.C. Rothwell, B.L. Day, P.D. Thompson, A. Ferbert, S. Wroe, P. Asselman, and C.D. Marsden Corticocortical inhibition in human motor cortex J. Physiol. 471 1993 Nov 501 519
31. U. Kumar, and S.C. Patel Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain Brain Res. 1131 2007 187 196
32. 3 receptors enhances monoaminergic and cholinergic neurotransmission in the rat anterior cingulate cortex Neuropsychopharmacology 28 5 2003 May 839 849
33. N. Lang, S. Speck, J. Harms, H. Rothkegel, W. Paulus, and M. Sommer Dopaminergic potentiation of rTMS-induced motor cortex inhibition Biol. Psychiatry 63 2008 231 233
34. 2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]raclopride Proc. Natl. Acad. Sci. U. S. A. 86 16 1989 Aug 6412 6416
35. J. Liepert, K.J. Bar, U. Meske, and C. Weiller Motor cortex disinhibition in Alzheimer's disease Clin. Neurophysiol. 112 8 2001 1436 1441
36. A.R. Luft, and S. Schwarz Dopaminergic signals in primary motor cortex Int. J. Dev. Neurosci. 27 5 2009 Aug 415 421
37. A. Martorana, A. Stefani, M.G. Palmieri, Z. Esposito, G. Bernardi, G. Sancesario, and M. Pierantozzi l-dopa modulates motor cortex excitability in Alzheimer's disease patients J. Neural Transm. 115 2008 1313 1319
38. A. Martorana, F. Mori, and Z. Esposito Dopamine modulates cholinergic cortical excitability in Alzheimer's disease patients Neuropsychopharmacology 34 10 2009 2323 2328
39. A. Martorana, Z. Esposito, and G. Koch Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease? CNS Neurosci. Ther. 16 4 2010 235 245
40. A. Martorana, R. Semprini, and G. Koch Clinical profile of Alzheimer's disease non-responder patient Raymond Chuen-Chung Chang, Advanced Understanding of Neurodegenerative Diseases 2011 InTech 978-953-307-529-7
41. 2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats Psychopharmacology (Berl.) 174 3 2004 Jul 341 357
42. M.J. Millan, B. Di Cara, A. Dekeyne, F. Panayi, L. De Groote, D. Sicard, L. Cistarelli, R. Billiras, and A. Gobert Selective blockade of dopamine D(3) versus D(2) receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis J. Neurochem. 100 2007 1047 1056
43. K. Molina-Luna, A. Pekanovic, S. Röhrich, B. Hertler, M. Schubring-Giese, M.S. Rioult-Pedotti, and A.R. Luft Dopamine in motor cortex is necessary for skill learning and synaptic plasticity PLoS One 4 9 2009 Sep 17 e7082
44. E. Mura, S. Preda, S. Govoni, C. Lanni, L. Trabace, M. Grilli, F. Lagomarsino, A. Pittaluga, and M. Marchi Specific neuromodulatory actions of amyloid-beta on dopamine release in rat nucleus accumbens and caudate putamen J. Alzheimers Dis. 19 2010 1041 1053
45. E. Mura, C. Lanni, S. Preda, F. Pistoia, M. Sarà, M. Racchi, G. Schettini, M. Marchi, and S. Govoni Beta-amyloid: a disease target or a synaptic regulator affecting age-related neurotransmitter changes? Curr. Pharm. Des. 16 6 2010 672 683
46. A.M. Murray, F.B. Weihmueller, J.F. Marshall, H.I. Hurtig, G.L. Gottleib, and J.N. Joyce Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism Ann. Neurol. 37 1995 300 312
47. M. Musicco, G. Salamone, C. Caltagirone, L. Cravello, L. Fadda, F. Lupo, S. Mosti, R. Perri, and K. Palmer Neuropsychological predictors of rapidly progressing patients with Alzheimer's disease Dement. Geriatr. Cogn. Disord. 30 3 2010 219 228
48. R. Nardone, H. Ausserer, A. Bratti, M. Covi, P. Lochner, R. Marth, and F. Tezzon Cabergoline reverses cortical hyperexcitability in patients with restless legs syndrome Acta Neurol. Scand. 114 4 2006 Oct 244 249
49. R. Nardone, J. Bergmann, M. Kronbichler, A. Kunz, S. Klein, F. Caleri, F. Tezzon, G. Ladurner, and S. Golaszewski Abnormal short latency afferent inhibition in early Alzheimer's disease: a transcranial magnetic demonstration J. Neural Transm. 115 11 2008 Nov 1557 1562
50. 1 dopamine receptors in primate prefrontal cortex: target-specific expression in the glutamatergic synapse J. Neurosci. 25 5 2005 Feb 2 1260 1267
51. G. Pennisi, G. Alagona, R. Ferri, S. Greco, D. Santonocito, A. Pappalardo, and R. Bella Motor cortex excitability in Alzheimer disease: one year follow-up study Neurosci. Lett. 329 3 6 2002 293 296
52. G. Pennisi, R. Ferri, G. Lanza, M. Cantone, M. Pennisi, V. Puglisi, G. Malaguarnera, and R. Bella Transcranial magnetic stimulation in Alzheimer's disease: a neurophysiological marker of cortical hyperexcitability J. Neural Transm. 118 4 2011 Apr 587 598
53. J.L. Pepin, D. Bogacz, V. de Pasqua, and P.J. Delwaide Motor cortex inhibition is not impaired in patients with Alzheimer's disease: evidence from paired transcranial magnetic stimulation J. Neurol. Sci. 170 2 1999 Nov 30 119 123
54. M. Pierantozzi, M. Panella, M.G. Palmieri, G. Koch, A. Giordano, M.G. Marciani, G. Bernardi, P. Stanzione, and A. Stefani Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia Clin. Neurophysiol. 115 10 2004 2410 2418
55. S. Preda, S. Govoni, C. Lanni, M. Racchi, E. Mura, M. Grilli, and M. Marchi Acute beta-amyloid administration disrupts the cholinergic control of dopamine release in the nucleus accumbens Neuropsychopharmacology 33 5 2008 Apr 1062 1070
56. P.M. Rossini, A.T. Barker, and A. Berardelli Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee Electroencephalogr. Clin. Neurophysiol. 91 1994 79 92
57. P.M. Rossini, S. Rossi, C. Babiloni, and J. Polich Clinical neurophysiology of aging brain: from normal aging to neurodegeneration Prog. Neurobiol. 83 6 2007 375 400
58. J.C. Rothwell Techniques and mechanisms of action of transcranial stimulation of the human motor cortex J. Neurosci. Methods 74 2 1997 Jun 27 113 122
59. A. Sailer, G.F. Molnar, G. Paradiso, C.A. Gunraj, A.E. Lang, and R. Chen Short and long latency afferent inhibition in Parkinson's disease Brain 126 2003 1883 1894
60. M. Sarter, J.P. Bruno, and J. Turchi Basal forebrain afferent projections modulating cortical acetylcholine, attention, and implications for neuropsychiatric disorders Ann. N. Y. Acad. Sci. 877 1999 368 382
61. J.K. Seamans, N. Gorelova, D. Durstewitz, and C.R. Yang Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons J. Neurosci. 21 10 2001 May 15 3628 3638
62. N. Thirugnanasambandam, J. Grundey, W. Paulus, and M.A. Nitsche J. Neurosci. 31 14 2011 Apr 6 5294 5299
63. H. Tokimura, V. Di Lazzaro, and Y. Tokimura Short latency inhibition of human hand motor cortex by somatosensory input from the hand J. Physiol. (Lond.) 523 2000 503 513
64. 2 dopamine receptors recruit a GABA component for their attenuation of excitatory synaptic transmission in the adult rat prefrontal cortex Synapse 61 10 2007 Oct 843 850
65. A.R. Varma, J.S. Snowden, J.J. Lloyd, P.R. Talbot, D.M. Mann, and D. Neary Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia J. Neurol. Neurosurg. Psychiatry 66 2 1999 184 188
66. 18F-N-methylspiroperidol Psychiatry Res. 67 1 1996 May 31 11 16
67. K.J. Werhahn, J.K. Fong, B.U. Meyer, A. Priori, J.C. Rothwell, B.L. Day, and P.D. Thompson The effect of magnetic coil orientation on the latency of surface EMG and single motor unit responses in the first dorsal interosseous muscle Electroencephalogr. Clin. Neurophysiol. 93 2 1994 Apr 138 146
68. L. Zhang, W.M. Doyon, J.J. Clark, P.E. Phillips, and J.A. Dani Controls of tonic and phasic dopamine transmission in the dorsal and ventral striatum Mol. Pharmacol. 76 2 2009 Aug 396 404
69. U. Ziemann, F. Tergau, D. Bruns, J. Baudewig, and W. Paulus Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs Electroencephalogr. Clin. Neurophysiol. 105 6 1997 430 437